marco m. aleman acting director, patents law division, wipo
DESCRIPTION
Regional Seminar on the multilateral legal framework and practice of patent protection in the pharmaceutical field Patent Policy and its Relation with other Policies. Issyk Kul , May 27 and 28, 2014. Marco M. ALEMAN Acting Director, Patents Law Division, WIPO. Outline. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/1.jpg)
Regional Seminar on the multilateral legal framework and practice of patent protection in the pharmaceutical field
Patent Policy and its Relation with other Policies
Marco M. ALEMAN
Acting Director, Patents Law Division, WIPO
Issyk Kul, May 27 and 28, 2014
![Page 2: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/2.jpg)
Outline
The international patent system
Objectives of the patent system
Trends on patents filing
Patent policies and its relation to other policies
![Page 3: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/3.jpg)
# 3
The international patent system
![Page 4: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/4.jpg)
Characteristics of Intellectual PropertyCharacteristics of Intellectual Property
Non-rivalrousness: simultaneous use by multiple entities no bottlenecks or capacity constraints
Non-excludability: use without authorization cannot be prevented
For static efficiency: optimal to permit free society-wide use as marginal cost low
For dynamic efficiency: need to prevent above, as incentives required to invest in creations, where social value exceeds development costs
![Page 5: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/5.jpg)
Therefore, societies faced with fundamental trade-off between two market distortions
Excessively weak IPRs, satisfy the static goal but inadequate incentives to create, leading to slower growth, limited culture, lower product quality
Excessively strong IPRs, consistent with dynamic goal but generate insufficient access, inadequate dissemination
Balance is imperative
……Characteristics of Intellectual PropertyCharacteristics of Intellectual Property
![Page 6: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/6.jpg)
Role of the StateRole of the State
To accelerate economic development need to:
arrest tendency to under invest in R&Dcreate incentives for additional investments
Intervention imperative for IP protection:
provides potential competitive advantage for innovatorcreates market distortions, but society benefits (in most cases, for a limited period of time, during the early period of the product life-cycle)
However, need to balance static efficiency for a specific innovation and the dynamic efficiency for a stream of inventions
![Page 7: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/7.jpg)
Main features of patent rightsProperty rights in inventions
may be sold or licensedRight to stop others from making or selling the invention without a patent owner’s consent- NOT a right to make or sell the invention
Only available for new inventions in a field of technologyNeed to fulfill conditions of patentability
Geographically limited under national patent lawsbut there are regional and international treaties
Limited duration, 20 years from filing dateAnnual renewal or maintenance fees (increasing with time)Some limitations to the rights
![Page 8: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/8.jpg)
1. Inventions
Products or processes
2. New
not included in the state of the art
3. Inventive stepno obvious for the expert in the field
4. Industrial applicability
The Patent SystemThe Patent SystemThe Patent SystemThe Patent System
![Page 9: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/9.jpg)
Objectives of the patent system
![Page 10: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/10.jpg)
Objectives of the patent system
The system, based on private rights, should effectively serve the public interest (both right holders and society) by contributing to innovation and diffusion of knowledge
Features of the system to achieve these objectives
- Granting exclusives rights to the inventor to promote innovation
- Granting valid patents after the invention has pass the test of objective standards (patentability criteria)
- Disclosure of the invention to allow diffusion of knowledge
![Page 11: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/11.jpg)
Patents and Technology Diffusion
The patent system is generally understood to facilitate technology diffusion; for some, it is even a prerequisite for technology transfer
It does that mainly via
patent information and
by using patents as an instrument to assist technology transfer
Several countries have in the past relied on the patent system as a tool in developing the national economy and this assisted it in promoting FDI and transfer of technology (e.g. Japan, Republic of Korea)
Other countries also show a correlation:
India: FDI growth followed the patent reform in 1990s
Brazil: FDI growth followed the introduction of a new industrial property law in 1996 (US$ 4.4 billion in 1995 to US$ 32.8 billion in 2000)
![Page 12: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/12.jpg)
Innovation and commercialization
New invention
Exploitation of patent
Publication ofapplications & patents
Patent application
Further innovation by third parties
Recovery of investment through - exclusive use- licensing- sale
Patentgranted
Further innovation by third parties
![Page 13: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/13.jpg)
Trends on Patents filing
![Page 14: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/14.jpg)
Filings
The number of patent applications filed worldwide totaled 2.35 million in 2012 (approximately 1.51 million resident applications and 0.83 million non-resident applications)
This represented growth of 9.2% on 2011 figures – the highest over the past 18 years (SIPO accounted for 72.6% of this total increase, USPTO for the 14.6% and KIPO accounted for and 5.2% each of this total increase).
14
![Page 15: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/15.jpg)
![Page 16: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/16.jpg)
![Page 17: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/17.jpg)
![Page 18: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/18.jpg)
![Page 19: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/19.jpg)
Patent policies and its relation to other policies
![Page 20: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/20.jpg)
There are several IP policies that addressed the challenge of striking a balance with other policies
(Examples)
University and Public Research policies
Competition policies and
Health policies on innovation and access to medicines
![Page 21: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/21.jpg)
Innovation with public funds
Dinamarca. Act of June 2 of 1999; and
USA. Act of 1980 “Bay Dole Act”.
![Page 22: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/22.jpg)
2222
Stanford: “something that all of us at OTL share is the “something that all of us at OTL share is the feeling of satisfaction that comes from knowing that we have feeling of satisfaction that comes from knowing that we have helped to bring a new technology to the market”.helped to bring a new technology to the market”.
En 35 años han logrado 2500 Acuerdos de Licencias o de En 35 años han logrado 2500 Acuerdos de Licencias o de opciones. Ejemplosopciones. Ejemplos::i) Microarrays; ii) Genscan;iii) Insulate gate bipolar transistor; iv) FM sound and i) Microarrays; ii) Genscan;iii) Insulate gate bipolar transistor; iv) FM sound and physical modeling and v) Improved Hypertext Searching (Google).physical modeling and v) Improved Hypertext Searching (Google).
IP and transfer of technology IP and transfer of technology
![Page 23: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/23.jpg)
2323
M.I.T. “General Policy Statement”:
“The prompt and open dissemination of the results of M.I.T. research and the free exchange of information among scholars are essential to the fulfillment of the M.I.T´s obligations as an institution committed to excellence in education and research. Matters of ownership, distribution, and commercial developments, nonetheless, arise in the context of technology transfer, which is an important aspect of M.I.T´s commitment to public service. Technology transfer is however subordinate to education and research; and the dissemination of information must, therefore, not be delayed beyond the minimal period necessary to define and protect the rights of the parties”
IP and transfer of technology (2) IP and transfer of technology (2)
![Page 24: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/24.jpg)
Goals of Competition policy
Broad Goal. To promote and maintain inter-firm rivalry. This is achieved in two ways: First, the adoption of competition laws to addressed anti-competitive market structure and enterprises' practices that impede competition and second, remove government measures that create obstacles to trade and competition.
More specific goals:
i) economic efficiency (allocate efficiency, productive efficiency and dynamic efficiency)
ii) consumer welfare (price charge and choice available to consumers).
![Page 25: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/25.jpg)
IP and Competition Interface
OECD (1998):
“At the highest level of analysis IPR and competition policies are complementary because they share a concern to promote technical progress to the ultimate benefit of consumers. Firms are more likely to innovate if they are at least somewhat protected against free-riding. They are also more likely to innovate if they face strong competition.”
“Despite sharing important goals intellectual property rights (IPR) and competition policies are not purely complementary policies and managing the interface between them can be difficult.”
![Page 26: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/26.jpg)
Multilateral legal framework
Art. 8.2 of TRIPS. Appropriate measures may be needed.
Art. 40.1 of TRIPS. Some licensing practices or conditions may restrain competition.
Art. 40. 2 of TRIPS. Members to take measure to prevent anticompetitive abuses of IP Rights. Illustrative list: grant back; No-Challenge; and Patent Tying clauses.
![Page 27: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/27.jpg)
IP MATERS RELATED TO COMPETITION
REFUSAL TO DEAL. The US Patent Law of 1988. The EU approached (more liberal essential facility doctrine)
Acquisition (standards of patentability, scope of the claims, patents to technical standards)
Enforcement of IP Rights (injunctions, abuse of patents rights and patent trolls); (European Commission Pharmaceutical Inquiry)
Compulsory licenses to remedy anti-competitive practice
Patent pools
Research collaboration agreements
Anticompetitive clauses: (no-challenge, grant back and patent tying clauses)
![Page 28: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/28.jpg)
2828
Patents and related health policiesPatents and related health policies
Patent and access to medicines
Patent law provisions that help to improve policy coherence are those dealing with:
1. Patentability subject matter
2. Limitations and exception to patent rights ( research exc., regulatory review exc., CLs and exhaustion)
3. Term of protection (public domain/Generics
Doha Declaration on IP and Public Health (transition periods for LDCs and paragraph 6)
![Page 29: Marco M. ALEMAN Acting Director, Patents Law Division, WIPO](https://reader036.vdocument.in/reader036/viewer/2022062407/56812b99550346895d8fbc65/html5/thumbnails/29.jpg)
Many [email protected]